{"id":"https://openalex.org/W4289869093","doi":"https://doi.org/10.3389/fonc.2022.915629","title":"Tumor-specific T cell-mediated upregulation of PD-L1 in myelodysplastic syndrome cells does not affect T-cell killing","display_name":"Tumor-specific T cell-mediated upregulation of PD-L1 in myelodysplastic syndrome cells does not affect T-cell killing","publication_year":2022,"publication_date":"2022-08-05","ids":{"openalex":"https://openalex.org/W4289869093","doi":"https://doi.org/10.3389/fonc.2022.915629","pmid":"https://pubmed.ncbi.nlm.nih.gov/35992887","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9389224"},"language":"en","primary_location":{"id":"doi:10.3389/fonc.2022.915629","doi":"https://doi.org/10.3389/fonc.2022.915629","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2022.915629","pdf_url":null,"source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.3389/fonc.2022.915629","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5079200066","display_name":"Valentina Ferrari","orcid":"https://orcid.org/0000-0001-8506-7076","observed_orcids":["https://orcid.org/0000-0001-8506-7076"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Valentina Ferrari","raw_affiliation_strings":["PersImmune, Inc., San Diego, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PersImmune, Inc., San Diego, CA, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050313059","display_name":"Alison Tarke","orcid":"https://orcid.org/0000-0002-2464-6549","observed_orcids":["https://orcid.org/0000-0002-2464-6549"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alison Tarke","raw_affiliation_strings":["PersImmune, Inc., San Diego, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PersImmune, Inc., San Diego, CA, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047965950","display_name":"Hannah F. Fields","orcid":"https://orcid.org/0000-0003-1966-0853","observed_orcids":["https://orcid.org/0000-0003-1966-0853"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hannah Fields","raw_affiliation_strings":["PersImmune, Inc., San Diego, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PersImmune, Inc., San Diego, CA, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012252175","display_name":"Tiffany N. Tanaka","orcid":"https://orcid.org/0000-0002-7656-5249","observed_orcids":["https://orcid.org/0000-0002-7656-5249"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]},{"id":"https://openalex.org/I4390039236","display_name":"Moores Cancer Center","ror":"https://ror.org/01qkmtm61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800935791","https://openalex.org/I36258959","https://openalex.org/I4390039236"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tiffany N. Tanaka","raw_affiliation_strings":["Moores Cancer Center, Department of Hematology and Oncology, University of California San Diego, La Jolla, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moores Cancer Center, Department of Hematology and Oncology, University of California San Diego, La Jolla, CA, United States","institution_ids":["https://openalex.org/I36258959","https://openalex.org/I4390039236"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076142846","display_name":"Stephen C. Searles","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]},{"id":"https://openalex.org/I4390039236","display_name":"Moores Cancer Center","ror":"https://ror.org/01qkmtm61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800935791","https://openalex.org/I36258959","https://openalex.org/I4390039236"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephen Searles","raw_affiliation_strings":["The Laboratory of Immunology, Department of Medicine and Moores Cancer Center, University of California San Diego, La Jolla, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Laboratory of Immunology, Department of Medicine and Moores Cancer Center, University of California San Diego, La Jolla, CA, United States","institution_ids":["https://openalex.org/I36258959","https://openalex.org/I4390039236"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5062279037","display_name":"Maurizio Zanetti","orcid":"https://orcid.org/0000-0001-6346-8776","observed_orcids":["https://orcid.org/0000-0001-6346-8776"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]},{"id":"https://openalex.org/I4390039236","display_name":"Moores Cancer Center","ror":"https://ror.org/01qkmtm61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800935791","https://openalex.org/I36258959","https://openalex.org/I4390039236"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Maurizio Zanetti","raw_affiliation_strings":["The Laboratory of Immunology, Department of Medicine and Moores Cancer Center, University of California San Diego, La Jolla, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Laboratory of Immunology, Department of Medicine and Moores Cancer Center, University of California San Diego, La Jolla, CA, United States","institution_ids":["https://openalex.org/I36258959","https://openalex.org/I4390039236"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5062279037","https://openalex.org/A5079200066"],"corresponding_institution_ids":["https://openalex.org/I36258959","https://openalex.org/I4390039236"],"apc_list":{"value":2950,"currency":"USD","value_usd":2950},"apc_paid":{"value":2950,"currency":"USD","value_usd":2950},"fwci":0.3139,"has_fulltext":true,"cited_by_count":4,"citation_normalized_percentile":{"value":0.54411631,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"12","issue":null,"first_page":"915629","last_page":"915629"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.0020000000949949026,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pd-l1-upregulation","display_name":"PD-L1 upregulation","score":0.9520000219345093},{"id":"https://openalex.org/keywords/pd-1-pd-l1-axis","display_name":"PD-1/PD-L1 axis","score":0.8889999985694885},{"id":"https://openalex.org/keywords/myelodysplastic-syndrome","display_name":"myelodysplastic syndrome","score":0.9869999885559082},{"id":"https://openalex.org/keywords/tumor-specific-t-cells","display_name":"tumor-specific T cells","score":0.9769999980926514},{"id":"https://openalex.org/keywords/t-cell-mediated-cytotoxicity","display_name":"T cell cytotoxicity","score":0.7480000257492065},{"id":"https://openalex.org/keywords/perk","display_name":"PERK","score":0.7089999914169312},{"id":"https://openalex.org/keywords/unfolded-protein-response","display_name":"unfolded protein response","score":0.9990000128746033},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.8510000109672546},{"id":"https://openalex.org/keywords/adoptive-t-cell-therapy","display_name":"adoptive T cell therapy","score":0.828000009059906},{"id":"https://openalex.org/keywords/hematological-cancer","display_name":"hematologic cancer","score":0.6600000262260437},{"id":"https://openalex.org/keywords/immune-evasion","display_name":"immune evasion","score":0.5799999833106995}],"concepts":[{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.8587919473648071},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.6769940853118896},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5862494707107544},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5836799144744873},{"id":"https://openalex.org/C2781053074","wikidata":"https://www.wikidata.org/wiki/Q21100639","display_name":"PD-L1","level":4,"score":0.5574465394020081},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5572117567062378},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.4595254063606262},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.4178633987903595},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.40490078926086426},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.33210012316703796},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.32211166620254517},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.06358429789543152},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.059661686420440674},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3389/fonc.2022.915629","doi":"https://doi.org/10.3389/fonc.2022.915629","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2022.915629","pdf_url":null,"source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9389224","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9389224","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Oncol","raw_type":"Text"},{"id":"pmid:35992887","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35992887","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in oncology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:e332476630c5488a88d3d7e592e6ceb5","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/e332476630c5488a88d3d7e592e6ceb5","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Oncology, Vol 12 (2022)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fonc.2022.915629","doi":"https://doi.org/10.3389/fonc.2022.915629","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2022.915629","pdf_url":null,"source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":22,"referenced_works":["https://openalex.org/W1561349380","https://openalex.org/W1977603207","https://openalex.org/W1983973479","https://openalex.org/W2067677489","https://openalex.org/W2106082819","https://openalex.org/W2118771330","https://openalex.org/W2131593570","https://openalex.org/W2183421496","https://openalex.org/W2297773450","https://openalex.org/W2587980604","https://openalex.org/W2612431515","https://openalex.org/W2619738298","https://openalex.org/W2767183168","https://openalex.org/W2772063923","https://openalex.org/W2782998220","https://openalex.org/W2800050586","https://openalex.org/W2966459681","https://openalex.org/W2988644538","https://openalex.org/W3033290435","https://openalex.org/W3042591665","https://openalex.org/W3108511913","https://openalex.org/W3110507746"],"related_works":["https://openalex.org/W2561112845","https://openalex.org/W2537146822","https://openalex.org/W3158678825","https://openalex.org/W4214813136","https://openalex.org/W2914866647","https://openalex.org/W4390964555","https://openalex.org/W2903581584","https://openalex.org/W2980955830","https://openalex.org/W7006164703","https://openalex.org/W3015575990"],"abstract_inverted_index":{"The":[0],"PD-1:PD-L1":[1,107],"axis":[2],"is":[3,45],"a":[4,25,42,52,102],"binary":[5],"interaction":[6],"that":[7,44,59,79,114],"delivers":[8],"inhibitory":[9],"signals":[10],"to":[11,20,64,119,129],"T":[12,29,85],"cells,":[13],"impeding":[14],"both":[15],"immune":[16,122],"surveillance":[17],"and":[18,47,112],"response":[19],"immunotherapy.":[21],"Here":[22],"we":[23,57,77],"analyzed":[24],"phenomenon":[26],"whereby":[27],"tumor-specific":[28,84],"cells":[30,37,86],"induce":[31],"PD-L1":[32,60,94],"upregulation":[33,61],"in":[34,38,109],"autologous":[35],"MDS":[36,96],"short-term":[39],"culture,":[40],"through":[41],"mechanism":[43],"cell-contact-independent":[46],"partially":[48],"IFN\u03b3-dependent.":[49],"After":[50],"investigating":[51],"panel":[53],"of":[54,71,83,93,106],"small-molecule":[55],"inhibitors,":[56],"determined":[58],"was":[62,87],"attributed":[63],"the":[65,72,80,91],"PKR-like":[66],"ER":[67],"kinase":[68],"(PERK)":[69],"branch":[70],"unfolded":[73],"protein":[74],"response.":[75],"Interestingly,":[76],"found":[78],"cytotoxic":[81],"capacity":[82],"not":[88,125],"impaired":[89],"by":[90],"expression":[92],"on":[95],"target":[97],"cells.":[98],"These":[99],"results":[100],"highlight":[101],"little":[103],"appreciated":[104],"aspect":[105],"regulation":[108],"hematologic":[110],"cancers":[111],"indicate":[113],"this":[115],"phenomenon,":[116],"while":[117],"likely":[118],"hinder":[120],"autochthonous":[121],"surveillance,":[123],"may":[124],"be":[126],"an":[127],"obstacle":[128],"immunotherapies":[130],"such":[131],"as":[132],"personalized":[133],"adoptive":[134],"T-cell":[135],"therapy.":[136]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1}],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2022-08-05T00:00:00"}